BTSG

BrightSpring Health Services, Inc. Common Stock

BTSG
Closed
$71.09
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. The company is headquartered in Louisville, Kentucky and currently employs 23,500 full-time employees. The company went IPO on 2024-01-26. Through the Company’s service lines, including pharmacy, home health care and rehabilitation, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. The company provides infused, injectable, and oral medication services in the home and clinic. Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care.
Country

US

CEO

Mr. Jon Rousseau

IPO date

2024

Employees

23,500

ISIN

US10950A1060

Key stats

Open

$72.30

Volume

2.05M

Market cap

$14.05B

Prev. close

$71.58

Impl / hst vl

-

Open interest

$0.00

$70.11

Day’s Range

$73.09

$36.87

52W Range

$72.06

Valuation

50
Valuation score
Fairly Valued
P/E
45.33
P/S
1.03
P/B
7.10
Current ratio
1.74
Debt / Equity
0.82
ROE
16.72%
Gross margin
13.34%
Income growth
93.00%
FCF growth
-47.70

Analysts estimates

Consensus rating
Buy

The average rating from top 14 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$67.64
The top 18 analysts forecasts that 12-month price may decrease by 4.85%, with a low of $49.49 and a high of $94.50
$49.49
Low
$67.64
Avg
$94.50
High
Current price

Earnings

Q1 ‘26 revenue
$3.61B
Q1 ‘26 net income
$148.77M
Revenue
Net income
Previous EPS
$0.39
Estimate EPS
$0.40
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply